Biohaven Ltd. (BHVN)
NYSE: BHVN · Real-Time Price · USD
8.96
-0.13 (-1.43%)
At close: Mar 19, 2026, 4:00 PM EDT
9.14
+0.18 (2.03%)
After-hours: Mar 19, 2026, 7:00 PM EDT
Biohaven Market Cap
Biohaven has a market cap or net worth of $1.35 billion as of March 19, 2026. Its market cap has decreased by -57.36% in one year.
Market Cap
1.35B
Enterprise Value
1.31B
1-Year Change
-57.36%
Ranking
Category
Stock Price
$8.96
Market Cap Chart
Since September 23, 2022, Biohaven's market cap has increased from $261.58M to $1.35B, an increase of 415.23%. That is a compound annual growth rate of 60.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 19, 2026 | 1.35B | -10.03% |
| Dec 31, 2025 | 1.50B | -60.34% |
| Dec 31, 2024 | 3.78B | 9.99% |
| Dec 29, 2023 | 3.43B | 262.97% |
| Dec 30, 2022 | 946.07M | 261.68% |
| Sep 23, 2022 | 261.58M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Trevi Therapeutics | 1.37B |
| MBX Biosciences | 1.35B |
| Ardelyx | 1.35B |
| Palvella Therapeutics | 1.35B |
| Zenas BioPharma | 1.34B |
| Rapport Therapeutics | 1.31B |
| Taysha Gene Therapies | 1.31B |
| Vir Biotechnology | 1.31B |